Eanm has launched a new award to accelerate alpha radioligand therapy research in prostate cancer, with winners to be announced at the EANM’26 Congress.
Applications are now open for the 2026 EANM Young Scientist Network Award. The research award is supported by Advanced Accelerator Applications, a Novartis company, and focuses on advancing alpha radioligand therapy in prostate cancer.
Alpha radioligand therapy, also known as α-RLT, is a targeted treatment that delivers radiation directly to cancer cells using radioactive particles attached to specific molecules, limiting damage to surrounding tissue.
Winners will be recognised in three categories: Platinum (€40,000), Gold (€20,000) and Silver (€10,000).
Paola Anna Erba, EANM president, said: “Alpha radioligand therapy is rapidly emerging as a transformative frontier in precision oncology, and we strongly believe in the talent of researchers at the beginning of their careers in this field. This award was designed to nurture their growth by pairing research excellence with structured training, mentorship, and collaborative networking opportunities.”
Eanm invites applications from early career researchers including PhD candidates, postdoctoral fellows, junior faculty and clinicians in training who are within 10 years of their terminal degree and affiliated with an institution in an EANM member country.
Applicants must submit a project proposal aimed at delivering clinically meaningful advances in prostate cancer treatment using α-RLT. Priority areas include optimising clinical use, tailoring treatment to individual patients and identifying those most likely to benefit. The deadline for applications is 18 May 2026 at 23:59 CEST via ysn@eanm.org.
Winners will be announced at the EANM’26 Congress, held from 17 to 21 October at the Austria Center Vienna, Austria. Awardees will present their projects during a dedicated session and take part in an interactive workshop with the scientific review committee to further develop their proposals.
Full details on eligibility and how to apply are available from Eanm.
